Harte Hanks Inc (HHS) Stock Analysis and Metrics

Harte Hanks

NASDAQ: HHS

$2.39 ▼ -0.01 (-0.42%)

At close: Jul 23, 2026 · 4:00 PM UTC

Financial Ratios

Market Cap17.72 Mn

P/E-16.82

P/S0.11

Div. Yield0.00

ROIC (Qtr)0.00

Revenue Growth (1y) (Qtr)-10.34

Add ratio to table…

About

Harte Hanks, Inc. is a global business experience outsourcing company that operates at the intersection of data marketing sales customer care fulfillment and logistics. The firm helps clients design activate and optimize the full customer and product lifecycle. With offices in North America Asia Pacific and Europe Harte Hanks serves leading global brands enabling them to achieve measurable business outcomes. The company draws on a heritage that traces back to a newspaper business founded in the early nineteen twenties and has evolved into a modern provider of outsourced solutions that combine data insight creative execution and operational excellence. Harte Hanks leverages a global delivery model that combines onshore expertise with offshore capacity to provide cost effective solutions while maintaining high service standards. The firm’s portfolio spans from data collection and analysis to campaign execution customer support and physical product distribution allowing clients to outsource entire functions or select individual components as needed.

Revenue is generated by delivering a broad suite of services that span data analytics marketing strategy creative execution customer care outsourcing and fulfillment logistics. The company sells these capabilities to businesses in sectors such as technology healthcare consumer products travel hospitality financial services automotive and retail. Clients pay for projects or ongoing engagements based on scope volume and performance metrics. Harte Hanks emphasizes a consultative approach that begins with understanding client objectives then designs tailored solutions that integrate data driven insights with technology enabled delivery and ends with measurable improvements in customer acquisition retention and satisfaction. Revenue streams are diversified across project based fees retainer agreements and performance linked incentives that align vendor compensation with client success metrics. The company also generates income from licensing its proprietary platforms and from providing training and change management services that help clients adopt new technologies and processes.

The company operates through the following segments.

• Data marketing demand generation and managed marketing services helps clients determine detect and activate audiences through traditional digital and emerging channels offering services such as data analytics research intelligence strategy creative content marketing technology digital multi channel marketing execution demand generation account based managed marketing services inside sales outsourcing lead generation and sales play development. The segment also offers consulting services that help clients build data governance frameworks and develop marketing technology roadmaps.

• Customer care provides customized support that includes customer service outsourcing customer care technology and AI transformation and self service technology to help clients attract buyers resolve queries and build loyalty. Customer care teams use artificial intelligence tools to triage inquiries and provide agents with real time suggestions that improve resolution speed and consistency.

• Fulfillment and logistics offers print on demand promotional distribution custom kitting event fulfillment product recall management temperature controlled storage and scalable global fulfillment along with third party logistics freight optimization services. Logistics specialists design custom routing plans and negotiate carrier contracts to reduce transit times and lower overall supply chain costs for customers.

Harte Hanks holds a competitive position as a provider of integrated customer and brand experience solutions across multiple service categories. The firm faces competition from local national and international marketing advertising customer care print fulfillment and smaller third party logistics companies as well as from internal client teams that may bring services in house. Key differentiators include the breadth and depth of its service portfolio its technical and strategic expertise its reputation for delivering measurable outcomes and its ability to price services attractively while maintaining quality. The company invests in proprietary technology such as its NexTOUCH and Allink 360 platforms to enhance efficiency and differentiate its offerings from rivals that rely solely on manual processes or generic software solutions. Harte Hanks also benefits from long standing relationships with major technology platforms and data providers which give it early access to emerging tools and insights. The firm’s focus on measurable outcomes and transparent reporting helps it win business in competitive procurement processes where clients seek clear return on investment.

The company serves a diverse client base that includes large multinational enterprises small and medium sized businesses and government organizations across industries such as technology healthcare consumer products travel hospitality financial services automotive and retail. No single customer accounts for more than a modest share of revenue with the largest client contributing roughly ten percent of total sales in 2025. Harte Hanks builds long term relationships typically ranging from one to three years and structures contracts that allow clients to scale services up or down without significant penalties. This approach helps the firm maintain stability while adapting to changing market demands and client needs. The firm’s client list includes Fortune 500 companies mid market enterprises and public sector agencies that rely on Harte Hanks for specialized projects such as product launches patient engagement programs and holiday promotional campaigns. Geographic diversification of revenue reduces reliance on any single market and provides a buffer against regional economic fluctuations.

Investment Thesis

▲ Bull case

The FedRAMP 'Agency Auth In Process' designation secured through HHS sponsorship represents a critical validation of Tecsys' Elite platform security architecture, positioning the company to capture significant share in the U.S. federal healthcare supply chain market where compliance requirements are non-negotiable and switching costs are extremely high, as achieving Class C Certification will enable Tecsys to bid on contracts previously inaccessible due to stringent federal mandates, creating a durable revenue stream from long-term government agreements that often span 5-10 years with built-in escalation clauses.
Tecsys' existing footprint with over 1,000 customer sites globally and more than 50 major health systems provides a proven foundation for rapid FedRAMP-certified platform adoption, as the company can leverage its established relationships with healthcare institutions that also serve as federal contractors or receive HHS funding, creating a natural cross-sell opportunity where compliance achievements in the public sector enhance credibility and trust in the commercial healthcare market, thereby accelerating enterprise sales cycles and reducing customer acquisition costs.
The Elite platform's recognition as a Gartner Challenger for 15 consecutive years in Warehouse Management Systems demonstrates sustained product excellence and innovation capacity, which, when combined with FedRAMP certification, creates a powerful differentiator in an increasingly crowded supply chain software market where security and compliance are becoming table stakes, allowing Tecsys to command premium pricing and resist commoditization pressures that plague competitors lacking equivalent federal validation.
HHS sponsorship signals deepening strategic alignment between Tecsys and U.S. federal healthcare initiatives, suggesting potential for future co-development opportunities or preferred vendor status in national supply chain resilience programs, particularly as pandemic-era lessons have heightened focus on securing medical logistics networks, which could unlock additional funding streams beyond standard software licensing, including government grants or consortium participation fees tied to national infrastructure modernization efforts.
The progression toward FedRAMP Class C Certification addresses a material unspoken risk in Tecsys' current business model: over-reliance on cyclical distribution and healthcare sectors vulnerable to economic downturns, as federal government spending on healthcare infrastructure and supply chain security tends to be counter-cyclical and politically insulated, providing a stabilizing revenue buffer that could smooth earnings volatility and attract institutional investors seeking defensive growth exposure in the software sector.

The FedRAMP 'Agency Auth In Process' designation secured through HHS sponsorship represents a critical validation of Tecsys' Elite platform security architecture, positioning the company to capture significant share in the U.S. federal healthcare supply chain market where compliance requirements are non-negotiable and switching costs are extremely high, as achieving Class C Certification will enable Tecsys to bid on contracts previously inaccessible due to stringent federal mandates, creating a durable revenue stream from long-term government agreements that often span 5-10 years with built-in escalation clauses.
Tecsys' existing footprint with over 1,000 customer sites globally and more than 50 major health systems provides a proven foundation for rapid FedRAMP-certified platform adoption, as the company can leverage its established relationships with healthcare institutions that also serve as federal contractors or receive HHS funding, creating a natural cross-sell opportunity where compliance achievements in the public sector enhance credibility and trust in the commercial healthcare market, thereby accelerating enterprise sales cycles and reducing customer acquisition costs.
The Elite platform's recognition as a Gartner Challenger for 15 consecutive years in Warehouse Management Systems demonstrates sustained product excellence and innovation capacity, which, when combined with FedRAMP certification, creates a powerful differentiator in an increasingly crowded supply chain software market where security and compliance are becoming table stakes, allowing Tecsys to command premium pricing and resist commoditization pressures that plague competitors lacking equivalent federal validation.
HHS sponsorship signals deepening strategic alignment between Tecsys and U.S. federal healthcare initiatives, suggesting potential for future co-development opportunities or preferred vendor status in national supply chain resilience programs, particularly as pandemic-era lessons have heightened focus on securing medical logistics networks, which could unlock additional funding streams beyond standard software licensing, including government grants or consortium participation fees tied to national infrastructure modernization efforts.
The progression toward FedRAMP Class C Certification addresses a material unspoken risk in Tecsys' current business model: over-reliance on cyclical distribution and healthcare sectors vulnerable to economic downturns, as federal government spending on healthcare infrastructure and supply chain security tends to be counter-cyclical and politically insulated, providing a stabilizing revenue buffer that could smooth earnings volatility and attract institutional investors seeking defensive growth exposure in the software sector.

▼ Bear case

Despite the positive FedRAMP designation, Tecsys faces significant execution risk in completing Class C Certification, as the process is notoriously lengthy and expensive, often requiring 18-36 months and substantial investment in third-party audits, continuous monitoring systems, and organizational restructuring, with no guarantee of success given the platform's complexity and the evolving nature of federal security standards, which could strain financial resources and divert management focus from core commercial operations if certification efforts encounter delays or require unexpected remediation.
The company's reliance on HHS sponsorship, while beneficial, creates a potential vulnerability to shifts in federal procurement priorities or budget allocations, as changes in administration or healthcare policy could deprioritize supply chain security initiatives, leaving Tecsys with a certified platform that lacks sufficient market demand if government agencies redirect funding toward alternative technologies or consolidate vendors, thereby undermining the expected return on the substantial upfront investment required for certification.
Tecsys' current customer base, while extensive in healthcare and distribution, may not translate seamlessly to the federal market, as government procurement involves vastly different sales cycles, compliance overhead, and customization demands that could erode margins, particularly if the Elite platform requires significant re-engineering to meet specific agency workflows or legacy system integrations, potentially leading to cost overruns and dissatisfaction and schedule overruns that negate the pricing power anticipated from FedRAMP status.
The competitive landscape for FedRAMP-certified supply chain solutions is intensifying, with larger, better-resourced enterprise software vendors actively pursuing federal healthcare contracts through established FedRAMP authorizations and deeper relationships with agency IT departments, putting Tecsys at a disadvantage in head-to-head bids despite its niche expertise, as federal buyers often prioritize vendor scale and past performance over specialized functionality when assessing risk in mission-critical deployments.
Tecsys' financial disclosures do not adequately quantify the ongoing operational costs associated with maintaining FedRAMP compliance post-certification, including continuous monitoring, annual assessments, and required security updates, which represent a permanent increase in cost of goods sold that could compress profitability if not fully offset by premium pricing or volume growth, especially given the company's historical reliance on perpetual licensing models that are less compatible with the subscription-heavy, compliance-driven economics of federal cloud contracts.

Despite the positive FedRAMP designation, Tecsys faces significant execution risk in completing Class C Certification, as the process is notoriously lengthy and expensive, often requiring 18-36 months and substantial investment in third-party audits, continuous monitoring systems, and organizational restructuring, with no guarantee of success given the platform's complexity and the evolving nature of federal security standards, which could strain financial resources and divert management focus from core commercial operations if certification efforts encounter delays or require unexpected remediation.
The company's reliance on HHS sponsorship, while beneficial, creates a potential vulnerability to shifts in federal procurement priorities or budget allocations, as changes in administration or healthcare policy could deprioritize supply chain security initiatives, leaving Tecsys with a certified platform that lacks sufficient market demand if government agencies redirect funding toward alternative technologies or consolidate vendors, thereby undermining the expected return on the substantial upfront investment required for certification.
Tecsys' current customer base, while extensive in healthcare and distribution, may not translate seamlessly to the federal market, as government procurement involves vastly different sales cycles, compliance overhead, and customization demands that could erode margins, particularly if the Elite platform requires significant re-engineering to meet specific agency workflows or legacy system integrations, potentially leading to cost overruns and dissatisfaction and schedule overruns that negate the pricing power anticipated from FedRAMP status.
The competitive landscape for FedRAMP-certified supply chain solutions is intensifying, with larger, better-resourced enterprise software vendors actively pursuing federal healthcare contracts through established FedRAMP authorizations and deeper relationships with agency IT departments, putting Tecsys at a disadvantage in head-to-head bids despite its niche expertise, as federal buyers often prioritize vendor scale and past performance over specialized functionality when assessing risk in mission-critical deployments.
Tecsys' financial disclosures do not adequately quantify the ongoing operational costs associated with maintaining FedRAMP compliance post-certification, including continuous monitoring, annual assessments, and required security updates, which represent a permanent increase in cost of goods sold that could compress profitability if not fully offset by premium pricing or volume growth, especially given the company's historical reliance on perpetual licensing models that are less compatible with the subscription-heavy, compliance-driven economics of federal cloud contracts.

Geographical Breakdown of Revenue (2025)

Peer Comparison

Companies in the Conglomerates

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	MMM	3M Co	88.13 Bn	55.29	3.50	12.55 Bn
2	HON	Honeywell International Inc	78.15 Bn	587.62	2.08	36.79 Bn
3	VMI	Valmont Industries Inc	9.52 Bn	37.80	2.29	0.79 Bn
4	BBUC	Brookfield Business Corp	6.56 Bn	96.50	0.24	38.51 Bn
5	SEB	Seaboard Corp /De/	4.44 Bn	7.62	0.45	1.52 Bn
6	OTTR	Otter Tail Corp	3.87 Bn	13.78	2.94	1.13 Bn
7	TTI	Tetra Technologies Inc	1.18 Bn	62.23	1.87	0.18 Bn
8	DLX	Deluxe Corp	1.16 Bn	11.16	0.54	1.41 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Geographical Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password